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Abstract 
Incubation of Chinese hamster V-79 cells with either buthionine sulfoximine @SO) or diethylmaleate @EM) prior to exposure to Na&rQ resulted 
in a depletion of GSH. ESR study shows that the depletion of GSH by BSO caused an increase in the cellular level of Cr(V) intermediate without 
affecting the level of Cr(III) complex, whereas the levels of Cr(V) and (III) were both suppressed by the depletion of GSH by DEM. GSH depletion 
by DEM decreased cellular uptake of chromate more than that by BSO. Glutathione reductase activity in cells, which is capable of reducing Cr(VI), 
was una.tkcted by BSO, however a strong inhibition was observed in cells treated with DEM, indicating that DEM affects not only GSH levels but 
also Cr(VI)-reducing enxyme activity. Thus, the depletion of GSH in cells increases Cr(V) formation, based upon the effect of BSO. The role of 
intracellular GSH in Cr(V1) reduction is discussed. 
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1. Introduetlon 
Cr(V1) compounds are well known to be human car- 
cinogens [l]. They have been shown to produce DNA 
single strand breaks and DNA-protein crosslinks and to 
inhibit the activity of enzymes uch as glutathione reduc- 
tase (GR) in mammalian cells [24]. In contrast to 
Cr(III), Cr(V1) actively enters cells by the sulfate anion 
transport system and is then believed to be reduced 
through reactive intermediates uch as Cr(V) and (IV) to 
more stable Cr(II1) by cellular reductants including glu- 
tathione (GSH), ascorbic acid, riboflavin and flavoen- 
zymes including GR [24]. Thus, the generation of par- 
amagnetic hromium may play an important role in the 
cellular damage caused by Cr(V1). For instance, Cr(V) 
complexes have been reported to induce DNA breakage 
and %hydroxy-2’-deoxyguanosine in vitro as well as mu- 
tation in bacterial systems, and recent in vitro studies 
indicated that not only Cr(VI)/(V) but also the Cr(III)/ 
(II) redox couple serve as cyclical electron donors, in a 
Fenton-like reaction, to produce active oxygen species 
[5-81. Among the biological reductants, GSH has been 
reported to be present normally in millimolar concentra- 
tions in intact cells, and the modification of cellular GSH 
in cultured cells has been shown to alter the levels of 
DNA damage caused by Cr(VI) [9]. Furthermore, ESR 
studies have shown that Cr(II1) and Cr(V) complexes are 
formed during reduction of Cr(V1) by GSH in vitro, and 
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the formation of Cr(V) in rat thymocytes and human red 
blood cells treated with Cr(VI) has been reported to be 
suppressed by thiol-reactive agents such as diethylmal- 
eate (DEM) and N-ethylmaleimide, respectively [lO,l 11. 
However, none of these thiol depletors are specific for 
GSH alone, and the influence of GSH depletion by an 
agent such as buthionine sulfoximine (BSO) which can 
deplete the cellular store of GSH via competitive inhibi- 
tion of y glutamylcysteine synthetase [12], on the forma- 
tion of paramagnetic hromium in intact cells has not 
been investigated. 
In the present study, the effect of GSH depletion in 
Chinese hamster V-79 (V-79) cells by either BSO or 
DEM on the formation of paramagnetic hromium was 
investigated using ESR spectrometry. In addition, we 
examined cellular uptake of Cr(W), as well as the activity 
of Cr(VI)-reducing flavoenzymes such as GR in these 
GSH-depleted cells, to understand differences in the ef- 
fects of BSO and DEM on the formation of Cr(V) and 
Cr(II1). The role of intracellular GSH in Cr(VI) reduc- 
tion was discussed, based upon the effects of these deple- 
tors. 
2. Materials and methods 
Na,CrG, .4H,O (purity 99.7%) and the radioisotope N%%Q were 
obtained from Nacalai Tesque Inc. (Kyoto, Japan) and DuPont-New 
England Nuclear, respectively. 
V-79 cells were grown as previously described [13]. BSO (Sigma) was 
added to the complete growth medium at the time cells were plated. 
After 24 h treatment, logarithmically growing cells were rinsed twice 
with salts-glucose medium (50 mM Hepes @H 7.2) containing 10 mM 
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NaCl, 5 mM KCl, 2 mM CaCl,, and 5 mM glucose), and the cells were 
then treated for 2 h with Na,CrO, at 37“C in this maintenance medium. 
In the case of DEM experiments, logarithmically growing V-79 cells 
were pretreated for 2 h with 1 mM DEM in the complete growth 
medium and then treated with Na,CrO, for 2 h in salts-glucose medium. 
The total glutathione (oxidized and reduced) and CR activity in cells 
were determined as previously described [14,151, and the enzyme activ- 
ity was expressed as nmol of NADPH oxidized/min/mg protein [15]. 
The formation of paramagnetic hromium was examined in cells di- 
rectly by ESR spectrometry as previously described [13]. Briefly, 
40 x lo6 cells were placed into an ESR tube and were rapidly frozen in 
liquid nitrogen. ESR measurements were made at temperatures of 153K 
using a JES-FE3X spectrometer with a lOO-kHz field modulation, 8 
mW of microwave power, and a 4.0-G modulation amplitude. Cellular 
uptake of chromate was also estimated by radioisotope “Cr analysis 
as detailed in [ 131. 
3. Results and discussion 
cells pretreated with 5, 10 and 25 ,uM BSO, the signal 
intensity of Cr(V) increased up to 170% of the control 
(Table 1). In contrast, as was in the case of previous 
studies using Thiol-reactive agents [lO,l 11, 1 mM DEM 
pretreatment resulted in a decrease of Cr(V) signal inten- 
sity (Fig. lf, Table 1). With respect o Cr(II1) formation, 
the intensity of the broad ESR signal due to Cr(II1) 
(g = 2.03, LIA = 70@-800 G) was not affected by BSO 
(Fig. 2a-e), however, the intensity of Cr(II1) was reduced 
to about 60% of the control level by 1 mM DEM (Fig. 
2f, Table 1). These results indicated that the depletion of 
GSH by BSO caused an increase of Cr(V0) formation 
without affecting Cr(II1) level whereas the depletion by 
DEM decreased both paramagnetic hromium species in 
V-79 cells. 
We first examined the effect of treatment with BSO 
(l-25 PM) for 24 h or with 1 mM DEM for 2 h on the 
content of GSH in V-79 cells. Treatment with either BSO 
or DEM alone did not alter cell growth in V-79 cells 
(data not shown). As shown in Table 1, treatment of cells 
with 1, 5 and 10 ,uM BSO caused approximately 40, 85 
and 90% depletion of cellular GSH level, respectively, 
and 25 ,uM BSO or 1 mM DEM treatment resulted in a 
complete depletion ( > 98%) of GSH. 
To clarify whether these depletors exerted their effect 
by altering the cellular uptake of chromate, the intracel- 
lular levels of this metal were also examined, as shown 
in Table 1. Pretreatment with BSO (5, 10 and 25 PM) 
caused small but significant decreases (14, 22 and 23%) 
in the cellular level of chromium, and 1 mM DEM pre- 
treatment resulted in an approximately 50% reduction in 
cellular levels of this metal. 
Table 1 also shows the influence of GSH depletion by 
BSO or DEM on the ESR signal intensity of Cr(V) and 
Cr(II1) complexes in V-79 cells treated with 200 ,uM 
Na,CrO,, and their ESR spectra were shown in Figs. 1 
and 2. No significant ESR signal was obtained from cells 
incubated in the absence of NazCr04 or in the presence 
of depletors alone (data not shown). The ESR signal 
intensity due to Cr(V) (g = 1.989) in cells was not altered 
by a 40% depletion of GSH caused by 1 ,uM BSO (Fig. 
lb) compared to that observed in unpretreated Cr(VI)- 
treated cells (Fig. la, Table 1). However, as shown in 
Fig. lc-e, when the depletion of GSH exceeded 85% in 
Since the cellular reduction of Cr(V1) has been re- 
ported to be catalyzed by flavoenzymes uch as GR [2- 
4], we also investigated the influence of these depletors 
on GR activity in V-79 cells. Results showed that no 
significant alteration of enzyme activity was observed in 
cells treated with 25 ,uM BSO alone, however, the activity 
was strongly suppressed by 1 mM DEM (control, 
15.4 + 1.7 (S.D.); 25 PM BSO, 14.6 f 1.1; 1 mM DEM, 
2.5 f 0.2 nmol/min/mg protein, n = 4). 
Thiol-reactive agents such as DEM are well known to 
react with SH groups of proteins. Previous studies have 
shown that DEM has many metabolic effects including 
inhibition of cell division, respiration, and glycolysis [ 161. 
In fact, the present results showed that cellular treatment 
Table 1 
GSH depletion by BSO or DEM and their effects on the formation of paramagnetic chromium and chromate uptake of V-79 cells 
ESR signal intensity (%) 
Pretreatment GSH Na,CrO, CrCV) Cr(III) Cellular uptake of “Cr 
@M) (nmol/mg protein) @M) (mnol/106 cells) 
_ 15.81 f 1.92 200 100 100 6.36 + 0.53 
BSO, 1 9.92 f 1.98 200 104f 3 96+ 8 - 
5 2.26 + 0.26 200 128f 8 98f 18 5.44 + 0.20: 
10 1.09 f 0.07 200 146f 9 95 + 20 4.99 f 0.30* 
25 0.17 f 0.02 200 167 + 22 81 + 15 4.92 + 0.51* 
DEM, 1000 0.10 + 0.01 200 72 t 14 59+ 15 3.47 f. 0.13* 
Cells were pretreated with BSO (l-25 PM) for 24 h or with 1 mM DEM for 2 h in growth medium and then cellular levels of GSH were measured. 
In addition, cells pretreated with BSO or DEM were treated for 2 h with 200 ,uM Na,CrO, in salts-glucose medium. Following Na2Cr04 treatment, 
ESR spectra of paramagnetic chromium and “Cr uptake of cells were measured as described in section 2. Each value is the mean f S.D. (n ~3). 
*P < 0.05 compared to unpretreated - 200 ,uM Na@Q, treated cells (Student’s t-test). 
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Fig. 1. ESR spectra of Cr(v) complex at 153K. Cells were pretreated 
with 0 (a), 1 (b), 5 (c), 10 (d) and 25 ,uM (e) BSO for 24 h or with 1 mM 
DEM (f) for 2 h, and then treated for 2 h in salts-glucose medium with 
200 ,uM Na,CrO.,. Following treatment, an ESR signal was obtained 
from the cells. 
with DEM caused a strong inhibition of chromate-reduc- 
ing GR activity, indicating that the suppression of 
Cr(II1) and (V) by DEM might be associated not only 
with the decrease of cellular levels of GSH but also with 
the inhibition of chromate-reducing SH enzymes and/or 
protein. In addition, it is possible that DEM reacting 
with the SH group of the sulfate transport system inhib- 
its chromate uptake in cells. In contrast to DEM, treat- 
ment with BSO did not affect the activity of Cr(VI)- 
reducing GR in V-79 cells. Another study has also shown 
that complete GSH depletion by BSO could not sensitize 
the cells to the toxicity of paraquat as a herbicide, but 
that this toxicity was enhanced after complete GSH de- 
pletion by DEM, possibly due to the binding of DEM 
to protein [17]. Although a small but significant inhibi- 
tion ( c 23%) of chromium uptake was observed in BSO- 
treated cells, in contrast to those results with DEM, the 
present results observed with BSO, in which the deple- 
tion of GSH caused an increase of Cr(V), may be primar- 
ily due to the effect of intracellular GSH depletion on the 
formation of paramagnetic hromium in V-79 cells. 
The present results with BSO showed that the levels of 
Cr(V) in GSH-depleted cells increased while the levels of 
Cr(II1) remained unchanged. This may be explained, in 
part, by the different intracellular concentrations of 
Cr(II1) and (V). As shown in Fig. 2, when the relative 
concentrations of Cr(V) and Cr(II1) in cells were esti- 
mated by analyzing the areas under their ESR signals, 
the concentrations of Cr(II1) were found to be about 30 
times greater than those of Cr(V) [ 131, indicating that the 
levels of Cr(V) alteration in the present study were rela- 
tively small as compared to the levels of Cr(II1). Simi- 
larly, pretreatment of V-79 cells with vitamin B, or E has 
been shown to modify the levels of Cr(V) without alter- 
ing the levels of Cr(II1) [2]. These results indicate that 
intracellular GSH may not be the major cellular reduc- 
tant to form Cr(III), but that the formation of Cr(V) 
appears to be closely associated with intracellular GSH 
levels. 
It is very interesting that the level of Ct(V) was in- 
creased in the > 85% GSH-depleted cells, but was not 
affected by the 40% depletion. Since BSO treatment de- 
creased cellular uptake of chromate and had no effect on 
chromate-reducing GR activity, the increase of Cr(V) by 
the depletion is unlikely to be related to alterations of the 
metal uptake and chromate-reducing GR activity. It is 
possible that, in V-79 cells containing > 60% of total 
GSH, the concentration of GSH may be fully adequate 
for reducing Cr(VI) to Cr(II1) without affecting Cr(V), 
however, in cells containing < 15% of total GSH, Cr(V1) 
could be reduced only to the Cr(V) level. This hypothesis 
is consistent with that of a previous study [19] and is 
a 
c, WV) 
Fig. 2. ESR spectra of Cr(III) complex at 153K. Same samples and ESR 
settings as in Fig. 1 except for the field scan. 
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supported by a recent in vitro study on the reaction of 
Cr(V1) and GSH using ESR spectroscopy [18]. These 
results suggested that the concentrations of Cr(V1) and 
GSH inside cells may be critical factors in the formation 
of Cr(V) complex. 
In conclusion, the present study showed that GSH 
depletion by BSO increased the formation of Cr(V> with- 
out altering the level of Cr(II1) while the levels of both 
Cr(V) and Cr(II1) were decreased after complete GSH 
depletion by DEM. These latter decreases might, how- 
ever, be attributed not only to intracellular GSH but also 
to the binding of DEM to protein, because DEM was 
found to strongly inhibit cellular uptake of chromate as 
well as chromate-reducing flavoenzymes such as GR. 
Since Cr(V) in particular may play a key role in the 
induction of Cr(V1) toxicity, mutagenicity and DNA al- 
teration [24], and since the molar ratio of Cr(V1) and 
GSH in cells may be associated with the induction of 
Cr(V1) damage, further study is needed to elucidate the 
precise role of intracellular GSH in the formation of 
paramagnetic hromium in a variety of tissues and cul- 
tured cells. 
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